Non‐small cell lung cancer harboring a rareEGFRL747P mutation showing intrinsic resistance to both gefitinib and osimertinib (AZD9291): A case report
Author:
Affiliation:
1. Department of Thoracic OncologyWest China Hospital, Sichuan University Chengdu China
2. Department of PathologyWest China Hospital, Sichuan University Chengdu China
3. Lung Cancer CenterWest China Hospital, Sichuan University Chengdu China
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.12637
Reference32 articles.
1. A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
2. Epidermal growth factor receptor mutations in lung cancer
3. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
4. Clinical experience with gefitinib: An update
5. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements of gene therapy in cancer treatment: A comprehensive review;Pathology - Research and Practice;2024-09
2. Screening of protein-based inhibitors for the intracellular domain of epidermal growth factor receptor by directed evolution using the yeast Gγ recruitment system;Journal of Bioscience and Bioengineering;2024-08
3. Gefitinib effectively treated advanced lung cancer with a rare EGFR L747P mutation in a kidney transplant recipient: the first case report;2023-11-30
4. EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast;Targeted Oncology;2023-10-04
5. Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening;Cancers;2023-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3